Silencing airway epithelial cell-derived hepcidin exacerbates sepsis-induced acute lung injury

Critical Care

Volumn 18, Issue 4, 2014, Pages

  Chen, Qi X ^a   Song, Sheng W ^b   Chen, Qing H ^a   Zeng, Cong L ^a   Zheng, Xia ^a   Wang, Jun L ^b   Fang, Xiang M ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FERROPORTIN; HEPCIDIN; INTERLEUKIN 6; IRON; MESSENGER RNA; SHORT HAIRPIN RNA;

ACUTE LUNG INJURY; ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CELL FUNCTION; CONTROLLED STUDY; DISEASE EXACERBATION; GENE; GENE SILENCING; GENETIC TRANSCRIPTION; HEPC1 GENE; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; MORTALITY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; SEPSIS; SURVIVAL RATE; UPREGULATION; ANIMAL; BACTERIAL COUNT; C57BL MOUSE; COMPLICATION; DISEASE COURSE; DISEASE MODEL; EPITHELIUM CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MIXED INFECTION; PHYSIOLOGY; RESPIRATORY SYSTEM;

ACUTE LUNG INJURY; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; COINFECTION; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIAL CELLS; HEPCIDINS; IMMUNOHISTOCHEMISTRY; IRON; MALE; MICE; MICE, INBRED C57BL; RESPIRATORY SYSTEM; SEPSIS; SURVIVAL RATE;

EID: 84910026542     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-014-0470-8     Document Type: Article

References (40)

1. Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012, 122:2731-2740. 10.1172/JCI60331, 22850883.
2. Leaver SK, Evans TW. Acute respiratory distress syndrome. BMJ 2007, 335:389-394. 10.1136/bmj.39293.624699.AD, 17717368.
3. Rubenfeld GD, Herridge MS. Epidemiology and outcomes of acute lung injury. Chest 2007, 131:554-562. 10.1378/chest.06-1976, 17296661.
4. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 2005, 353:1685-1693. 10.1056/NEJMoa050333, 16236739.
5. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, Scales DC, Stather DR, Li A, Jones A, Gattas DJ, Hallett D, Tomlinson G, Stewart TE, Ferguson ND. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 2009, 179:220-227. 10.1164/rccm.200805-722OC, 19011152.
6. Zambon M, Vincent JL. Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest 2008, 133:1120-1127. 10.1378/chest.07-2134, 18263687.
7. Doss M, White MR, Tecle T, Hartshorn KL. Human defensins and LL-37 in mucosal immunity. J Leukoc Biol 2010, 87:79-92. 10.1189/jlb.0609382, 19808939.
8. Hiemstra PS. Defensins and cathelicidins in inflammatory lung disease: beyond antimicrobial activity. Biochem Soc Trans 2006, 34:276-278. 10.1042/BST20060276, 16545093.
9. Starner TD, Agerberth B, Gudmundsson GH, McCray PB. Expression and activity of beta-defensins and LL-37 in the developing human lung. J Immunol 2005, 174:1608-1615. 10.4049/jimmunol.174.3.1608, 15661923.
10. Schaller-Bals S, Schulze A, Bals R. Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am J Respir Crit Care Med 2002, 165:992-995. 10.1164/ajrccm.165.7.200110-020, 11934727.
11. Ashitani J, Mukae H, Arimura Y, Sano A, Tokojima M, Nakazato M. High concentrations of alpha-defensins in plasma and bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Life Sci 2004, 75:1123-1134. 10.1016/j.lfs.2004.01.028, 15207659.
12. Shu Q, Shi Z, Zhao Z, Chen Z, Yao H, Chen Q, Hoeft A, Stuber F, Fang X. Protection against Pseudomonas aeruginosa pneumonia and sepsis-induced lung injury by overexpression of beta-defensin-2 in rats. Shock 2006, 26:365-371. 10.1097/01.shk.0000224722.65929.58, 16980883.
13. Ganz T. Hepcidin and iron regulation, 10years later. Blood 2011, 117:4425-4433. 10.1182/blood-2011-01-258467, 21346250.
14. Muckenthaler MU. Fine tuning of hepcidin expression by positive and negative regulators. Cell Metab 2008, 8:1-3. 10.1016/j.cmet.2008.06.009, 18590684.
15. Pietrangelo A. Hepcidin in human iron disorders: therapeutic implications. J Hepatol 2011, 54:173-181. 10.1016/j.jhep.2010.08.004, 20932599.
16. Gardenghi S, Ramos P, Marongiu MF, Melchiori L, Breda L, Guy E, Muirhead K, Rao N, Roy CN, Andrews NC, Nemeth E, Follenzi A, An X, Mohandas N, Ginzburg Y, Rachmilewitz EA, Giardina PJ, Grady RW, Rivella S. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. J Clin Invest 2010, 120:4466-4477. 10.1172/JCI41717, 21099112.
17. Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science 2012, 338:768-772. 10.1126/science.1224577, 23139325.
18. Ganz T. Iron in innate immunity: starve the invaders. Curr Opin Immunol 2009, 21:63-67. 10.1016/j.coi.2009.01.011, 19231148.
19. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell 2010, 142:24-38. 10.1016/j.cell.2010.06.028, 20603012.
20. De Domenico I, Zhang TY, Koening CL, Branch RW, London N, Lo E, Daynes RA, Kushner JP, Li D, Ward DM, Kaplan J. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest 2010, 120:2395-2405. 10.1172/JCI42011, 20530874.
21. Huang YH, Yang YL, Tiao MM, Kuo HC, Huang LT, Chuang JH. Hepcidin protects against lipopolysaccharide-induced liver injury in a mouse model of obstructive jaundice. Peptides 2012, 35:212-217. 10.1016/j.peptides.2012.03.032, 22504010.
22. Frazier MD, Mamo LB, Ghio AJ, Turi JL. Hepcidin expression in human airway epithelial cells is regulated by interferon-γ. Respir Res 2011, 12:100. 10.1186/1465-9921-12-100, 21810240.
23. Lou DQ, Nicolas G, Lesbordes JC, Viatte L, Grimber G, Szajnert MF, Kahn A, Vaulont S. Functional differences between hepcidin 1 and 2 in transgenic mice. Blood 2004, 103:2816-2821. 10.1182/blood-2003-07-2524, 14604961.
24. Lesbordes-Brion JC, Viatte L, Bennoun M, Lou DQ, Ramey G, Houbron C, Hamard G, Kahn A, Vaulont S. Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 2006, 108:1402-1405. 10.1182/blood-2006-02-003376, 16574947.
25. Sasu BJ, Cooke KS, Arvedson TL, Plewa C, Ellison AR, Sheng J, Winters A, Juan T, Li H, Begley CG, Molineux G. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood 2010, 115:3616-3624. 10.1182/blood-2009-09-245977, 20053755.
26. Chen Q, Zhang K, Jin Y, Zhu T, Cheng B, Shu Q, Fang X. Triggering receptor expressed on myeloid cells-2 protects against polymicrobial sepsis by enhancing bacterial clearance. Am J Respir Crit Care Med 2013, 188:201-212. 10.1164/rccm.201211-1967OC, 23721075.
27. Snelgrove RJ, Goulding J, Didierlaurent AM, Lyonga D, Vekaria S, Edwards L, Gwyer E, Sedgwick JD, Barclay AN, Hussell T. A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat Immunol 2008, 9:1074-1083. 10.1038/ni.1637, 18660812.
28. Hofer H, Osterreicher C, Jessner W, Penz M, Steindl-Munda P, Wrba F, Ferenci P. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C. J Hepatol 2004, 40:1018-1022. 10.1016/j.jhep.2004.02.030, 15158344.
29. Sun L, Guo RF, Gao H, Sarma JV, Zetoune FS, Ward PA. Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells. FASEB J 2009, 23:3808-3818. 10.1096/fj.09-133694, 19620403.
30. Lomas-Neira JL, Chung CS, Wesche DE, Perl M, Ayala A. In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury. J Leukoc Biol 2005, 77:846-853. 10.1189/jlb.1004617, 15695553.
31. Bao S, Liu MJ, Lee B, Besecker B, Lai JP, Guttridge DC, Knoell DL. Zinc modulates the innate immune response in vivo to polymicrobial sepsis through regulation of NF-kappaB. Am J Physiol Lung Cell Mol Physiol 2010, 298:L744-L754. 10.1152/ajplung.00368.2009, 20207754.
32. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093. 10.1126/science.1104742, 15514116.
33. Qiao B, Sugianto P, Fung E, Del-Castillo-Rueda A, Moran-Jimenez MJ, Ganz T, Nemeth E. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab 2012, 15:918-924. 10.1016/j.cmet.2012.03.018, 22682227.
34. Turi JL, Yang F, Garrick MD, Piantadosi CA, Ghio AJ. The iron cycle and oxidative stress in the lung. Free Radic Biol Med 2004, 36:850-857. 10.1016/j.freeradbiomed.2003.12.008, 15019970.
35. Heming N, Lettéron P, Driss F, Millot S, El Benna J, Tourret J, Denamur E, Montravers P, Beaumont C, Lasocki S. Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia. Crit Care Med 2012, 40:2141-2148. 10.1097/CCM.0b013e31824e6713, 22564959.
36. Polati R, Castagna A, Bossi AM, Alberio T, De Domenico I, Kaplan J, Timperio AM, Zolla L, Gevi F, D'Alessandro A, Brunch R, Olivieri O, Girelli D. Murine macrophages response to iron. J Proteomics 2012, 76:10-27. 10.1016/j.jprot.2012.07.018, 22835775.
37. Krause A, Neitz S, Mägert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000, 480:147-150. 10.1016/S0014-5793(00)01920-7, 11034317.
38. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, Holmdahl R, Nicholls J, Jiang C, Binder CJ, Penninger JM. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008, 133:235-249. 10.1016/j.cell.2008.02.043, 18423196.
39. Wang L, Harrington L, Trebicka E, Shi HN, Kagan JC, Hong CC, Lin HY, Babitt JL, Cherayil BJ. Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J Clin Invest 2009, 119:3322-3328. 19809161.
40. Wang L, Johnson EE, Shi HN, Walker WA, Wessling-Resnick M, Cherayil BJ. Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. J Immunol 2008, 181:2723-2731. 10.4049/jimmunol.181.4.2723, 18684963.